BETAGAN
Manufacturer Details
ALLERGAN
1st Floor North Wing
Silver Jubilee Block
Unity Building Complex
Mission Road
Bangalore 560227
Compositions:
Levobunolol 5mg/ml drops,
|
Strength
|
Rate
|
Packing Style
|
|
5mg/ml drops
|
163.38
|
5ml Eye drops
|
List of Related Indications:
- Chronic open angle glaucoma
- Ocular hypertension
List Of Drugs:
- Levobunolol - @Beta-adrenergic blocking agent- (May 1996)
Indication Type Description:
Pharmacology/ Pharmacokinetics
Drug Interaction:
Concomittant use with ephinephrine may cause mydriasis additive systemic effects with systemic usuage of beta-blockers and catecholamine-depletors(reserpine).
Indication:
Lowering IOP in chronic open- angle glaucoma or ocular hypertension
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Levobunolol HCl 16-05-1996
For control of Intra Ocular pressure in chronic open angle glaucoma
and ocular hypertension
Adverse Reaction:
Ocular stinging,burning,blepharoconjuntivitis,decreased heart rate,decreased B.P.,indocycitis, headache,transcient ataxia,dizziness,lethargy,decreased corneal sensitivity,urticaria and puritus.
Contra-Indications:
Broncial asthmal/severe COPD sinus bradycardia second and third degree heart block overt catdiac failure cardiogenic shock hypersensitivity.
Special precautions:
In patients with acute respiratory disorders excercise caution. Continued myocardiac depression may lead to cardiac failure. Look for the clue and withdraw the medicament if required. Avoid contamination with the nozzle tip. Caution in diabetes melitus,pregnancy and lactation.
Dosages/ Overdosage Etc:
Approved by (DCI) Drug Controller GENERAL - India For Marketing (Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Levobunolol HCl 16-05-1996
For control of Intra Ocular pressure in chronic open angle glaucoma
and ocular hypertension
Indication:
Lowering of IOP in chrinic open-angle glaucoma or ocular hypertension.
Dosage: Usual dose:
instill 1 drop in the affected eye(s) once or twice a day.
Patient Information:
Refer -Atenolol- Beta-adrenergic blocking agents
Pharmacology/ Pharmacokinetics:
Refer- Atenolol- Beta-adrenergic blocking agents
Interaction with Food:
Not applicable
Pregnancy and lactation:
Refer - Atenolol- Beta-adrenergic blocking agents
